In a historic trading session on Tuesday, cannabis stocks soared following the DEA's decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.

This regulatory shift aligning with a recommendation from the Department of Health and Human Services, sparked investor interest

evidenced by gains in major cannabis stocks on the NASDAQ.

Canopy Growth Corporation(NASDAQ:CGC) led the gains, skyrocketing by 78.8% to close at $14.88 per share amid a trading frenzy that pushed the volume to 79.25 million shares.

Aurora Cannabis (NASDAQ:ACB) wasn't far behind, climbing 46.0% to close at $9.23 per share with a volume...